CapsoVision (CV) Competitors $4.79 -0.01 (-0.21%) As of 10/3/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CV vs. BBNX, EMBC, TNDM, AXGN, CLPT, SIBN, BVS, AVNS, ZIMV, and BFLYShould you be buying CapsoVision stock or one of its competitors? The main competitors of CapsoVision include Beta Bionics (BBNX), Embecta (EMBC), Tandem Diabetes Care (TNDM), AxoGen (AXGN), ClearPoint Neuro (CLPT), SiBone (SIBN), Bioventus (BVS), Avanos Medical (AVNS), ZimVie (ZIMV), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry. CapsoVision vs. Its Competitors Beta Bionics Embecta Tandem Diabetes Care AxoGen ClearPoint Neuro SiBone Bioventus Avanos Medical ZimVie Butterfly Network Beta Bionics (NASDAQ:BBNX) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Does the media favor BBNX or CV? In the previous week, Beta Bionics had 8 more articles in the media than CapsoVision. MarketBeat recorded 11 mentions for Beta Bionics and 3 mentions for CapsoVision. Beta Bionics' average media sentiment score of 0.66 beat CapsoVision's score of -0.01 indicating that Beta Bionics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 4 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CapsoVision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is BBNX or CV more profitable? Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A CapsoVision N/A N/A N/A Which has preferable valuation and earnings, BBNX or CV? CapsoVision has lower revenue, but higher earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$78.02M12.40-$54.76MN/AN/ACapsoVision$12.52M17.90N/AN/AN/A Do analysts recommend BBNX or CV? Beta Bionics presently has a consensus price target of $24.44, indicating a potential upside of 9.81%. CapsoVision has a consensus price target of $5.50, indicating a potential upside of 14.82%. Given CapsoVision's higher possible upside, analysts plainly believe CapsoVision is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 1 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.69CapsoVision 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 SummaryBeta Bionics beats CapsoVision on 5 of the 7 factors compared between the two stocks. Get CapsoVision News Delivered to You Automatically Sign up to receive the latest news and ratings for CV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CV vs. The Competition Export to ExcelMetricCapsoVisionSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$224.52M$175.67M$2.53B$10.56BDividend YieldN/AN/A2.53%4.70%P/E RatioN/A1.9226.7926.71Price / Sales17.906.09112.20179.08Price / CashN/A3.8445.5861.25Price / BookN/A1.5737.946.56Net IncomeN/A-$51.31M$12.55M$277.70M7 Day Performance4.59%4.23%1.91%2.41%1 Month Performance26.72%-4.38%4.15%9.30%1 Year PerformanceN/AN/A60.37%31.22% CapsoVision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVCapsoVisionN/A$4.79-0.2%$5.50+14.8%N/A$224.52M$12.52M0.0090Short Interest ↑BBNXBeta Bionics2.1085 of 5 stars$19.53-11.7%$23.33+19.5%N/A$848.97M$65.12M0.00294News CoverageAnalyst UpgradeInsider TradeEMBCEmbecta4.803 of 5 stars$13.90+1.5%$19.00+36.7%+7.8%$812.94M$1.12B9.722,100Positive NewsTNDMTandem Diabetes Care4.3733 of 5 stars$12.00+0.3%$22.44+87.0%-63.6%$810.83M$940.20M-3.882,650AXGNAxoGen3.3091 of 5 stars$17.16+1.4%$26.00+51.5%+34.0%$789.58M$187.34M-171.58450Trending NewsAnalyst ForecastAnalyst RevisionCLPTClearPoint Neuro0.6845 of 5 stars$21.55+9.2%$19.67-8.7%+146.2%$612.60M$31.39M-26.60110News CoverageGap UpSIBNSiBone3.8967 of 5 stars$14.05-0.6%$23.67+68.4%+4.7%$606.13M$185.26M-25.09350Positive NewsBVSBioventus3.0792 of 5 stars$6.66-1.5%$13.75+106.5%-39.8%$550.64M$564.14M-10.921,200AVNSAvanos MedicalN/A$11.76+1.8%N/A-48.6%$546.15M$692.50M-1.172,227Positive NewsZIMVZimVie1.4316 of 5 stars$18.91flat$17.75-6.1%+21.0%$533.47M$449.75M-27.011,770News CoveragePositive NewsShort Interest ↓BFLYButterfly Network3.2541 of 5 stars$2.01+2.3%$3.00+49.6%+23.0%$506M$82.06M-7.16460Positive News Related Companies and Tools Related Companies BBNX Alternatives EMBC Alternatives TNDM Alternatives AXGN Alternatives CLPT Alternatives SIBN Alternatives BVS Alternatives AVNS Alternatives ZIMV Alternatives BFLY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CV) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CapsoVision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CapsoVision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
